208 related articles for article (PubMed ID: 12792670)
1. Chemogenomics knowledge-based strategies in drug discovery.
Jacoby E; Schuffenhauer A; Floersheim P
Drug News Perspect; 2003 Mar; 16(2):93-102. PubMed ID: 12792670
[TBL] [Abstract][Full Text] [Related]
2. An ontology for pharmaceutical ligands and its application for in silico screening and library design.
Schuffenhauer A; Zimmermann J; Stoop R; van der Vyver JJ; Lecchini S; Jacoby E
J Chem Inf Comput Sci; 2002; 42(4):947-55. PubMed ID: 12132896
[TBL] [Abstract][Full Text] [Related]
3. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands.
Klabunde T
Br J Pharmacol; 2007 Sep; 152(1):5-7. PubMed ID: 17533415
[TBL] [Abstract][Full Text] [Related]
4. Computational chemogenomics approaches to systematic knowledge-based drug discovery.
Mestres J
Curr Opin Drug Discov Devel; 2004 May; 7(3):304-13. PubMed ID: 15216933
[TBL] [Abstract][Full Text] [Related]
5. Protein-ligand interaction prediction: an improved chemogenomics approach.
Jacob L; Vert JP
Bioinformatics; 2008 Oct; 24(19):2149-56. PubMed ID: 18676415
[TBL] [Abstract][Full Text] [Related]
6. Chemogenomics: a discipline at the crossroad of high throughput technologies, biomarker research, combinatorial chemistry, genomics, cheminformatics, bioinformatics and artificial intelligence.
Maréchal E
Comb Chem High Throughput Screen; 2008 Sep; 11(8):583-6. PubMed ID: 18795877
[TBL] [Abstract][Full Text] [Related]
7. In silico pharmacology for drug discovery: applications to targets and beyond.
Ekins S; Mestres J; Testa B
Br J Pharmacol; 2007 Sep; 152(1):21-37. PubMed ID: 17549046
[TBL] [Abstract][Full Text] [Related]
8. Similarity metrics for ligands reflecting the similarity of the target proteins.
Schuffenhauer A; Floersheim P; Acklin P; Jacoby E
J Chem Inf Comput Sci; 2003; 43(2):391-405. PubMed ID: 12653501
[TBL] [Abstract][Full Text] [Related]
9. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.
Vieth M; Higgs RE; Robertson DH; Shapiro M; Gragg EA; Hemmerle H
Biochim Biophys Acta; 2004 Mar; 1697(1-2):243-57. PubMed ID: 15023365
[TBL] [Abstract][Full Text] [Related]
10. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
11. A chemogenomics view on protein-ligand spaces.
Strömbergsson H; Kleywegt GJ
BMC Bioinformatics; 2009 Jun; 10 Suppl 6(Suppl 6):S13. PubMed ID: 19534738
[TBL] [Abstract][Full Text] [Related]
12. Chemogenomics in drug discovery.
Kubinyi H
Ernst Schering Res Found Workshop; 2006; (58):1-19. PubMed ID: 16708995
[TBL] [Abstract][Full Text] [Related]
13. Chemogenomics: drug discovery's panacea?
Jacoby E
Mol Biosyst; 2006 May; 2(5):218-20. PubMed ID: 16880939
[TBL] [Abstract][Full Text] [Related]
14. Chemogenomics: structuring the drug discovery process to gene families.
Harris CJ; Stevens AP
Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
[TBL] [Abstract][Full Text] [Related]
15. Chemogenomics: an emerging strategy for rapid target and drug discovery.
Bredel M; Jacoby E
Nat Rev Genet; 2004 Apr; 5(4):262-75. PubMed ID: 15131650
[No Abstract] [Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Exploring the chemogenomic knowledge space with annotated chemical libraries.
Savchuk NP; Balakin KV; Tkachenko SE
Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
[TBL] [Abstract][Full Text] [Related]
18. A Structural Framework for GPCR Chemogenomics: What's In a Residue Number?
Vass M; Kooistra AJ; Verhoeven S; Gloriam D; de Esch IJP; de Graaf C
Methods Mol Biol; 2018; 1705():73-113. PubMed ID: 29188559
[TBL] [Abstract][Full Text] [Related]
19. Are target-family-privileged substructures truly privileged?
Schnur DM; Hermsmeier MA; Tebben AJ
J Med Chem; 2006 Mar; 49(6):2000-9. PubMed ID: 16539387
[TBL] [Abstract][Full Text] [Related]
20. Molecular approaches to receptors as targets for drug discovery.
Herz JM; Thomsen WJ; Yarbrough GG
J Recept Signal Transduct Res; 1997 Sep; 17(5):671-776. PubMed ID: 9292776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
